Analytical tools to assess aging in humans: The rise of geri-omics

TrAC - Trends in Analytical Chemistry

Volumn 80, Issue , 2016, Pages 204-212

  da Costa, João Pinto ^a   Rocha Santos, Teresa ^a   Duarte, Armando C ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

Aging; Bioinformatics; Metabolomics; Proteomics; Transcriptomics

Indexed keywords

AGING OF MATERIALS; MOLECULAR BIOLOGY; NEURODEGENERATIVE DISEASES;

BIOINFORMATIC TOOLS; CONTRIBUTING FACTOR; HEALTH-CARE SYSTEM; METABOLOMICS; NATURAL PROCESS; NEURODEGENERATIVE; PROTEOMICS; TRANSCRIPTOMICS;

BIOINFORMATICS;

AMYLOID BETA PROTEIN; APOLIPOPROTEIN A1; PROTEOME; RECEPTOR FOR ACTIVATED C KINASE 1; REGUCALCIN;

AGING; ALZHEIMER DISEASE; ANALYTICAL EQUIPMENT; BIOINFORMATICS; CELL AGING; DIAGNOSTIC KIT; DNA SEQUENCE; ECHOCARDIOGRAPHY; FATTY ACID METABOLISM; GEL ELECTROPHORESIS; HIGH THROUGHPUT SEQUENCING; HUMAN; INTEGROMICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; NEXT GENERATION SEQUENCING; OXIDATIVE STRESS; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA SEQUENCE; TANDEM MASS SPECTROMETRY; TRANSCRIPTOMICS;

EID: 84961743061     PISSN: 01659936     EISSN: 18793142     Source Type: Journal    
DOI: 10.1016/j.trac.2015.09.011     Document Type: Review

References (177)

1. Sandars N.K. The Epic of Gilgamesh: An English Verison with an Introduction 1960, Penguin Group, US.
2. Kirkwood T.B.L. Understanding the odd science of aging. Cell 2005, 120:437-447.
3. Rose M.R. Evolutionary Biology of Aging 1990, Oxford University Press.
4. Anton B., Vitetta L., Cortizo F., Sali A. Can we delay aging? The biology and science of aging. Ann. N. Y. Acad. Sci 2005, 1057:525-535.
5. Chew B.H., Shariff Ghazali S., Ismail M., Haniff J., Bujang M.A. Age ≥60 years was an independent risk factor for diabetes-related complications despite good control of cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp. Gerontol 2013, 48:485-491.
6. Andersen S., Laurberg P. Age impact on clinical risk factors does not justify the age related change in referral pattern for osteoporosis assessment - data from the Aalborg University Hospital Record for Osteoporosis Risk Assessment (AURORA). Maturitas 2015, 80:302-307.
7. Boccardi V., Pelini L., Ercolani S., Ruggiero C., Mecocci P. From cellular senescence to Alzheimer's disease: the role of telomere shortening. Ageing Res. Rev 2015, 22:1-8.
8. McDonald R.J., Craig L.A., Hong N.S. The etiology of age-related dementia is more complicated than we think. Behav. Brain Res 2010, 214:3-11.
9. Rowe J.W., Kahn R.L. Successful aging. Gerontologist 1997, 37:433-440.
10. Evans W. Biomarkers: The 10 Keys to Prolonging Vitality 1992, Touchstone.
11. Deutz N.E.P., Bauer J.M., Barazzoni R., Biolo G., Boirie Y., Bosy-Westphal A., et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr 2014, 33:929-936.
12. Dockree P.M., Brennan S., O'Sullivan M., Robertson I.H., O'Connell R.G. Characterising neural signatures of successful aging: electrophysiological correlates of preserved episodic memory in older age. Brain Cogn 2015, 97:40-50.
13. Harvey A., Montezano A.C., Touyz R.M. Vascular biology of ageing - implications in hypertension. J. Mol. Cell. Cardiol 2015, 83:112-121. http://dx.doi.org/10.1016/j.yjmcc.2015.04.011.
14. Martin N., Beach D., Gil J. Ageing as developmental decay: insights from p16INK4a. Trends Mol. Med 2014, 20:667-674.
15. Morgan T.E. Gene expression in normal aging brain. Encyclopedia of Neuroscience 2009, 591-595. Academic Press, Oxford. L.R. Squire (Ed.).
16. Tower J. Programmed cell death in aging. Ageing Res. Rev 2015, 23:90-100. http://dx.doi.org/10.1016/j.arr.2015.04.002.
17. Goldsmith T.C. On the programmed/non-programmed aging controversy. Biochemistry Mosc 2012, 77:729-732.
18. Blagosklonny M.V. Aging is not programmed. Cell Cycle 2013, 12:3736-3742.
19. Goldsmith T.C. Arguments against non-programmed aging theories. Biochemistry Mosc 2013, 78:971-978.
20. Goldsmith T. Modern evolutionary mechanics theories and resolving the programmed/non-programmed aging controversy. Biochemistry Mosc 2014, 79:1049-1055.
21. Goldsmith T.C. Aging theories and the zero-sum game. Rejuvenation Res 2014, 17:1-2.
22. Medvedev Z.A. An attempt at a rational classification of theories of ageing. Biol. Rev. Camb. Philos. Soc 1990, 65:375-398.
23. Bjorksten J. The crosslinkage theory of aging. J. Am. Geriatr. Soc 1968, 16:408-427.
24. Harman D. Free Radical Involvement in Aging. Drugs Aging 1993, 3:60-80.
25. Effros R.B. Roy Walford and the immunologic theory of aging. Immun. Ageing 2005, 2:7.
26. Kruk P.A., Rampino N.J., Bohr V.A. DNA damage and repair in telomeres: relation to aging. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:258-262.
27. Warner H.R., Sprott R.L., Schneider E.L., Butler R.N. Modern Biological Theories of Aging 1987.
28. Rattan S.I.S. Theories of biological aging: genes, proteins, and free radicals. Free Radic. Res 2006, 40:1230-1238.
29. Trindade L.S., Aigaki T., Peixoto A.A., Balduino A., Mânica da Cruz I.B., Heddle J.G. A novel classification system for evolutionary aging theories. Front. Genet 2013, 4:25.
30. Jin K. Modern biological theories of aging. Aging Dis 2010, 1:72-74.
31. Viña J., Borrás C., Miquel J. Theories of ageing. IUBMB Life 2007, 59:249-254.
32. Campisi J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol 2013, 75:685-705.
33. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
34. International Human Genome Sequencing Consortium Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
35. da Costa J.P., Oliveira-Silva R., Daniel-da-Silva A.L., Vitorino R. Bionanoconjugation for proteomics applications - an overview. Biotechnol. Adv 2014, 32:952-970.
36. Velculescu V.E., Zhang L., Zhou W., Vogelstein J., Basrai M.A., Bassett D.E., et al. Characterization of the yeast transcriptome. Cell 1997, 88:243-251.
37. Wilkins M.R., Pasquali C., Appel R.D., Ou K., Golaz O., Sanchez J.-C., et al. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and arnino acid analysis. Biotechnology (N.Y.) 1996, 14:61-65.
38. Gates S.C., Sweeley C.C. Quantitative metabolic profiling based on gas chromatography. Clin. Chem 1978, 24:1663-1673.
39. Valdes A.M., Glass D., Spector T.D. Omics technologies and the study of human ageing. Nat. Rev. Genet 2013, 14:601-607.
40. Nkuipou-Kenfack E., Koeck T., Mischak H., Pich A., Schanstra J.P., Zurbig P., et al. Proteome analysis in the assessment of ageing. Ageing Res. Rev 2014, 18:74-85.
41. Aquila P.D., Rose G., Bellizzi D., Passarino G. Epigenetics and aging. Maturitas 2013, 74:130-136.
42. Brunet A., Berger S.L. Epigenetics of aging and aging-related disease. J. Gerontol. A. Biol Sci. Med Sci 2014, 69(Suppl. 1):S17-S20.
43. Wheeler H.E., Kim S.K. Genetics and genomics of human ageing. Philos. Trans. R. Soc. Lond. B Biol. Sci 2011, 366:43-50.
44. Kulminski A., Culminskaya I. Genomics of human health and aging. Age (Dordr.) 2013, 35:455-469.
45. Atzmon G., Cho M., Cawthon R.M., Budagov T., Katz M., Yang X., et al. Evolution in health and medicine Sackler colloquium: genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(Suppl. 1):1710-1717.
46. Flachsbart F., Caliebe A., Kleindorp R., Blanche H., von Eller-Eberstein H., Nikolaus S., et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2700-2705.
47. Anselmi C.V., Malovini A., Roncarati R., Novelli V., Villa F., Condorelli G., et al. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res 2009, 12:95-104.
48. Glass D., Vinuela A., Davies M.N., Ramasamy A., Parts L., Knowles D., et al. Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol 2013, 14:R75.
49. Grondahl M.L., Yding Andersen C., Bogstad J., Nielsen F.C., Meinertz H., Borup R. Gene expression profiles of single human mature oocytes in relation to age. Hum. Reprod 2010, 25:957-968.
50. da Costa J.P., Cova M., Ferreira R., Vitorino R. Antimicrobial peptides: an alternative for innovative medicines?. Appl. Microbiol. Biotechnol 2015, 99:2023-2040. 1-18.
51. Hong M.-G., Myers A.J., Magnusson P.K., Prince J.A. Transcriptome-wide assessment of human brain and lymphocyte senescence. PLoS ONE 2008, 3. e3024.
52. Glaab E., Schneider R. Comparative pathway and network analysis of brain transcriptome changes during adult aging and in Parkinson's disease. Neurobiol. Dis 2015, 74:1-13.
53. Rodwell G.E., Sonu R., Zahn J.M., Lund J., Wilhelmy J., Wang L., et al. A transcriptional profile of aging in the human kidney. PLoS Biol 2004, 2:e427.
54. Berchtold N.C., Coleman P.D., Cribbs D.H., Rogers J., Gillen D.L., Cotman C.W. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol. Aging 2013, 34:1653-1661.
55. Pieters N., Janssen B.G., Valeri L., Cox B., Cuypers A., Dewitte H., et al. Molecular responses in the telomere-mitochondrial axis of ageing in the elderly: a candidate gene approach. Mech. Ageing Dev 2015, 145:51-57.
56. Reynolds L.M., Ding J., Taylor J.R., Lohman K., Soranzo N., de la Fuente A., et al. Transcriptomic profiles of aging in purified human immune cells. BMC Genomics 2015, 16:333.
57. Martin-Ruiz C., von Zglinicki T. Biomarkers of healthy ageing: expectations and validation. Proc. Nutr. Soc 2014, 73:422-429.
58. Silawat N., Savalia J., Patel D. Comparative study of impact of age on physiological variables, body composition and blood cholesterol in selected physical education professionals. JESP 2009, 5:5.
59. Driskell R.R., Watt F.M. Understanding fibroblast heterogeneity in the skin. Trends Cell Biol 2014, 25:92-99.
60. Grundberg E., Small K.S., Hedman Å.K., Nica A.C., Buil A., Keildson S., et al. Mapping cis-and trans-regulatory effects across multiple tissues in twins. Nat. Genet 2012, 44:1084-1089.
61. de Magalhães J.P., Curado J., Church G.M. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 2009, 25:875-881.
62. Sanchez D., Bajo-Grañeras R., Del Caño-Espinel M., Garcia-Centeno R., Garcia-Mateo N., Pascua-Maestro R., et al. Aging without Apolipoprotein D: molecular and cellular modifications in the hippocampus and cortex. Exp. Gerontol 2015, 67:19-47.
63. Zahn J.M., Sonu R., Vogel H., Crane E., Mazan-Mamczarz K., Rabkin R., et al. Transcriptional profiling of aging in human muscle reveals a common aging signature. PLoS Genet 2006, 2:e115.
64. Passos G.A. Transcriptomics in Health and Disease 2015, Springer International Publishing.
65. de Magalhães J.P., Finch C.E., Janssens G. Next-generation sequencing in aging research: emerging applications, problems, pitfalls and possible solutions. Ageing Res. Rev 2010, 9:315-323.
66. Tan Y.D., Chandler A.M., Chaudhury A., Neilson J.R. A powerful statistical approach for large-scale differential transcription analysis. PLoS ONE 2015, 10. e0123658.
67. Djuranovic S., Nahvi A., Green R. A parsimonious model for gene regulation by miRNAs. Science 2011, 331:550-553.
68. Wu L., Belasco J.G. Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol. Cell 2008, 29:1-7.
69. ElSharawy A., Keller A., Flachsbart F., Wendschlag A., Jacobs G., Kefer N., et al. Genome-wide miRNA signatures of human longevity. Aging Cell 2012, 11:607-616.
70. Hackl M., Brunner S., Fortschegger K., Schreiner C., Micutkova L., Mück C., et al. miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 2010, 9:291-296.
71. Smith-Vikos T., Slack F.J. MicroRNAs and their roles in aging. J. Cell Sci 2012, 125:7-17.
72. Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet 2009, 10:57-63.
73. Mazin P., Xiong J., Liu X., Yan Z., Zhang X., Li M., et al. Widespread splicing changes in human brain development and aging. Mol. Syst. Biol 2013, 9.
74. Caputo V., Sinibaldi L., Fiorentino A., Parisi C., Catalanotto C., Pasini A., et al. Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding. PLoS ONE 2011, 6. e28656.
75. Biggar K.K., Storey K.B. New approaches to comparative and animal stress biology research in the post-genomic era: a contextual overview. Comput. Struct. Biotechnol. J. 2014, 11:138-146.
76. Zhang Z.H., Jhaveri D.J., Marshall V.M., Bauer D.C., Edson J., Narayanan R.K., et al. A comparative study of techniques for differential expression analysis on RNA-seq data. PLoS ONE 2014, 9. e103207.
77. Law C.W., Chen Y., Shi W., Smyth G.K. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 2014, 15.
78. Li J., Witten D.M., Johnstone I.M., Tibshirani R. Normalization, testing, and false discovery rate estimation for RNA-sequencing data. Biostatistics 2011, 13:523-538. 10.1093/biostatistics/kxr031.
79. Dillies M.-A., Rau A., Aubert J., Hennequet-Antier C., Jeanmougin M., Servant N., et al. A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief. Bioinform 2013, 14:671-683.
80. Benson D.A., Cavanaugh M., Clark K., Karsch-Mizrachi I., Lipman D.J., Ostell J., et al. GenBank. Nucleic Acids Res 2013, 41:D36-D42.
81. Consortium E.P. The ENCODE (ENCyclopedia of DNA elements) project. Science 2004, 306:636-640.
82. Consortium T.G. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015, 348:648-660.
83. Bastian F., Parmentier G., Roux J., Moretti S., Laudet V., Robinson-Rechavi M. Bgee: Integrating and Comparing Heterogeneous Transcriptome Data Among Species, Data Integration in the Life Sciences 2008, 124-131. Springer.
84. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., et al. A Mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
85. Florea L., Hartzell G., Zhang Z., Rubin G.M., Miller W. A computer program for aligning a cDNA sequence with a genomic DNA sequence. Genome Res 1998, 8:967-974.
86. Iseli C., Jongeneel C.V., Bucher P. ESTScan: a program for detecting, evaluating, and reconstructing potential coding regions in EST sequences. Proc. Int. Conf. Intell. Syst. Mol. Biol 1999, 138-148.
87. Yang J.-H., Shao P., Zhou H., Chen Y.-Q., Qu L.-H. deepBase: a database for deeply annotating and mining deep sequencing data. Nucleic Acids Res 2010, 38:D123-D130.
88. Schanstra J.P., Mischak H. Proteomic urinary biomarker approach in renal disease: from discovery to implementation. Pediatr. Nephrol 2014, 30:713-725. 1-13.
89. Camerini S., Mauri P. The role of protein and peptide separation before mass spectrometry analysis in clinical proteomics. J. Chromatogr. A 2015, 1381:1-12.
90. Butterfield D.A. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment. Free Radic. Biol. Med 2014, 74:157-174.
91. Dai D.-F. Global Proteomics remodeling of cardiac aging and pressure-overload induced heart failure is attenuated by suppression RF target of rapamycin. J. Am. Coll. Cardiol 2014, 63:A2149.
92. Staunton L., Zweyer M., Swandulla D., Ohlendieck K. Mass spectrometry-based proteomic analysis of middle-aged vs. aged vastus lateralis reveals increased levels of carbonic anhydrase isoform 3 in senescent human skeletal muscle. Int. J. Mol. Med 2012, 30:723-733.
93. Zubiri I., Posada-Ayala M., Benito-Martin A., Maroto A.S., Martin-Lorenzo M., Cannata-Ortiz P., et al. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes. Transl. Res 2015, 166:474-484. http://dx.doi.org/10.1016/j.trsl.2015.05.007.
94. Baraibar M.A., Friguet B. Oxidative proteome modifications target specific cellular pathways during oxidative stress, cellular senescence and aging. Exp. Gerontol 2013, 48:620-625.
95. Baraibar M.A., Ladouce R., Friguet B. Proteomic quantification and identification of carbonylated proteins upon oxidative stress and during cellular aging. J. Proteomics 2013, 92:63-70.
96. Yi H., Li X.H., Yi B., Zheng J., Zhu G., Li C., et al. Identification of Rack1, EF-Tu and rhodanese as aging-related proteins in human colonic epithelium by proteomic analysis. J. Proteome Res 2010, 9:1416-1423.
97. Laimer M., Kocher T., Chiocchetti A., Trost A., Lottspeich F., Richter K., et al. Proteomic profiling reveals a catalogue of new candidate proteins for human skin aging. Exp. Dermatol 2010, 19:912-918.
98. Das A., Bortner J.D., Aliaga C.A., Baker A., Stanley A., Stanley B.A., et al. Changes in proteomic profiles in different prostate lobes of male rats throughout growth and development and aging stages of the life span. Prostate 2013, 73:363-375.
99. Ding J., Kopchick J.J. Plasma biomarkers of mouse aging. Age (Dordr.) 2011, 33:291-307.
100. Lu J., Huang Y., Wang Y., Li Y., Zhang Y., Wu J., et al. Profiling plasma peptides for the identification of potential ageing biomarkers in Chinese Han adults. PLoS ONE 2012, 7. e39726.
101. Bosman G.J.C.G.M., Lasonder E., Groenen-Döpp Y.A.M., Willekens F.L.A., Werre J.M. The proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation. J. Proteomics 2012, 76:203-210.
102. Bakun M., Senatorski G., Rubel T., Lukasik A., Zielenkiewicz P., Dadlez M., et al. Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction. Age (Dordr.) 2014, 36:299-311.
103. Zürbig P., Decramer S., Dakna M., Jantos J., Good D.M., Coon J.J., et al. The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics 2009, 9:2108-2117.
104. Wang Z., Li M. Evolution of the urinary proteome during human renal development and maturation. Adv. Exp. Med. Biol 2015, 95-101.
105. Morzel M., Jeannin A., Lucchi G., Truntzer C., Pecqueur D., Nicklaus S., et al. Human infant saliva peptidome is modified with age and diet transition. J. Proteomics 2012, 75:3665-3673.
106. Fleissig Y., Reichenberg E., Redlich M., Zaks B., Deutsch O., Aframian D.J., et al. Comparative proteomic analysis of human oral fluids according to gender and age. Oral Dis 2010, 16:831-838.
107. Berman H.M., Coimbatore Narayanan B., Costanzo L.D., Dutta S., Ghosh S., Hudson B.P., et al. Trendspotting in the protein data bank. FEBS Lett 2013, 587:1036-1045.
108. Silva A.M.N., Vitorino R., Domingues M.R.M., Spickett C.M., Domingues P. Post-translational modifications and mass spectrometry detection. Free Radic. Biol. Med 2013, 65:925-941.
109. Schneider M., Lane L., Boutet E., Lieberherr D., Tognolli M., Bougueleret L., et al. The UniProtKB/Swiss-Prot knowledgebase and its plant proteome annotation program. J. Proteomics 2009, 72:567-573.
110. Shpaer E.G., Robinson M., Yee D., Candlin J.D., Mines R., Hunkapiller T. Sensitivity and selectivity in protein similarity searches: a comparison of smith-waterman in hardware to BLAST and FASTA. Genomics 1996, 38:179-191.
111. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402.
112. Ma T., Liu Y., Dai Q., Yao Y., He P.-A. A graphical representation of protein based on a novel iterated function system. Phys. A Stat. Mech. Appl 2014, 403:21-28.
113. Plotree D., Plotgram D. PHYLIP-phylogeny inference package (version 3.2). Cladistics 1989, 5:163-166.
114. Overton I.M., Barton G.J. Computational approaches to selecting and optimising targets for structural biology. Methods 2011, 55:3-11.
115. Gasteiger E., Hoogland C., Gattiker A., Wilkins M.R., Appel R.D., Bairoch A. Protein identification and analysis tools on the ExPASy server. The Proteomics Protocols Handbook 2005, 571-607. Springer.
116. Cheng J., Randall A.Z., Sweredoski M.J., Baldi P. SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Res 2005, 33:W72-W76.
117. Kneller D.G., Cohen F.E., Langridge R. Improvements in protein secondary structure prediction by an enhanced neural network. J. Mol. Biol 1990, 214:171-182.
118. Tossi A., Sandri L., Giangaspero A. New consensus hydrophobicity scale extended to non-proteinogenic amino acids. Peptides 2002, 27:416.
119. Rice P., Longden I., Bleasby A. EMBOSS: the European molecular biology open software suite. Trends Genet 2000, 16:276-277.
120. Gupta R., Brunak S. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac. Symp. Biocomput 2002, 310-322.
121. Gao J., Thelen J.J., Dunker A.K., Xu D. Musite, a tool for global prediction of general and kinase-specific phosphorylation sites. Mol. Cell. Proteomics 2010, 9:2586-2600.
122. Heazlewood J.L., Durek P., Hummel J., Selbig J., Weckwerth W., Walther D., et al. PhosPhAt: a database of phosphorylation sites in Arabidopsis thaliana and a plant-specific phosphorylation site predictor. Nucleic Acids Res 2008, 36:D1015-D1021.
123. Taboureau O. Methods for building quantitative structure-activity relationship (QSAR) descriptors and predictive models for computer-aided design of antimicrobial peptides. Methods Mol. Biol 2010, 618:77-86.
124. Käll L., Krogh A., Sonnhammer E.L. Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server. Nucleic Acids Res 2007, 35:W429-W432.
125. Petersen T.N., Brunak S., von Heijne G., Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 2011, 8:785-786.
126. Goldschmidt L., Cooper D.R., Derewenda Z.S., Eisenberg D. Toward rational protein crystallization: a web server for the design of crystallizable protein variants. Protein Sci 2007, 16:1569-1576. DOI D - NLM: PMC2203352 EDAT- 2007/07/28 09:00 MHDA- 2007/10/30 09:00 CRDT- 2007/07/28 09:00 AID - 16/8/1569 [pii] AID - 10.1110/ps.072914007 [doi] PST - ppublish.
127. Ahmad Y., Lamond A.I. A perspective on proteomics in cell biology. Trends Cell Biol 2014, 24:257-264.
128. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455:1054-1056.
129. Bujak R., Struck-Lewicka W., Markuszewski M.J., Kaliszan R. Metabolomics for laboratory diagnostics. J. Pharm. Biomed. Anal 2015, 113:108-120. http://dx.doi.org/10.1016/j.jpba.2014.12.017.
130. Martínez-Arranz I., Mayo R., Pérez-Cormenzana M., Mincholé I., Salazar L., Alonso C., et al. Enhancing metabolomics research through data mining. J. Proteomics 2015, 127:275-288. http://dx.doi.org/10.1016/j.jprot.2015.01.019.
131. Pimenta L.P., Kim H.K., Verpoorte R., Choi Y.H. NMR-based metabolomics: a probe to utilize biodiversity. Methods Mol. Biol 2013, 1055:117-127.
132. Baker M. Metabolomics: from small molecules to big ideas. Nat. Methods 2011, 8:117-121.
133. DeBerardinis R.J., Thompson C.B. Cellular metabolism and disease: what do metabolic outliers teach us?. Cell 2012, 148:1132-1144.
134. Nunnari J., Suomalainen A. Mitochondria: in sickness and in health. Cell 2012, 148:1145-1159.
135. Halama A. Metabolomics in cell culture - a strategy to study crucial metabolic pathways in cancer development and the response to treatment. Arch. Biochem. Biophys 2014, 564:100-109.
136. Lefort N., Brown A., Lloyd V., Ouellette R., Touaibia M., Culf A.S., et al. 1H NMR metabolomics analysis of the effect of dichloroacetate and allopurinol on breast cancers. J. Pharm. Biomed. Anal 2014, 93:77-85.
137. Patel S., Ahmed S. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery. J. Pharm. Biomed. Anal 2015, 107:63-74.
138. Fillet M., Frédérich M. The emergence of metabolomics as a key discipline in the drug discovery process. Drug Discov. Today Technol 2015, 13:19-24. http://dx.doi.org/10.1016/j.ddtec.2015.01.006.
139. Zhao Y.-Y., Lin R.-C. Chapter three - metabolomics in nephrotoxicity. Advances in Clinical Chemistry 2014, 69-89. Elsevier. S.M. Gregory (Ed.).
140. Li M., Wang J., Lu Z., Wei D., Yang M., Kong L. NMR-based metabolomics approach to study the toxicity of lambda-cyhalothrin to goldfish (Carassius auratus). Aquat. Toxicol 2014, 146:82-92.
141. Ferrara M. 12 - Future perspectives for metabolomics in nutrition research: a nutritionist's view. Metabolomics as a Tool in Nutrition Research 2015, 231-236. Woodhead Publishing. J.L.S. Brennan (Ed.).
142. Inoue K., Tanada C., Sakamoto T., Tsutsui H., Akiba T., Min J.Z., et al. Metabolomics approach of infant formula for the evaluation of contamination and degradation using hydrophilic interaction liquid chromatography coupled with mass spectrometry. Food Chem 2015, 181:318-324.
143. Wang T.J., Larson M.G., Vasan R.S., Cheng S., Rhee E.P., McCabe E., et al. Metabolite profiles and the risk of developing diabetes. Nat. Med 2011, 17:448-453.
144. Boyle S.H., Matson W.R., Velazquez E.J., Samad Z., Williams R.B., Sharma S., et al. Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunction. Metabolomics 2015, 11:571-582.
145. Kaddurah-Daouk R., Yuan P., Boyle S.H., Matson W., Wang Z., Zeng Z.B., et al. Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Sci. Rep 2012, 2.
146. Want E.J., Masson P., Michopoulos F., Wilson I.D., Theodoridis G., Plumb R.S., et al. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat. Protocols 2013, 8:17-32.
147. Dunn W.B., Broadhurst D., Begley P., Zelena E., Francis-McIntyre S., Anderson N., et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc 2011, 6:1060-1083.
148. Sansone S.-A., Fan T., Goodacre R., Griffin J.L., Hardy N.W., Kaddurah-Daouk R., et al. The metabolomics standards initiative. Nat. Biotechnol 2007, 25:846-848.
149. Lawton K.A., Berger A., Mitchell M., Milgram K.E., Evans A.M., Guo L., et al. Analysis of the adult human plasma metabolome 2008, 9, 383-397.
150. Yu Z., Zhai G., Singmann P., He Y., Xu T., Prehn C., et al. Human serum metabolic profiles are age dependent. Aging Cell 2012, 11:960-967.
151. Seubert J.M., Zeldin D.C., Nithipatikom K., Gross G.J. Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. Prostaglandins Other Lipid Mediat 2007, 82:50-59.
152. Jira W., Spiteller G., Richter A. Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem. Phys. Lipids 1997, 87:81-89.
153. Menni C., Kastenmüller G., Petersen A.K., Bell J.T., Psatha M., Tsai P.-C., et al. Metabolomic markers reveal novel pathways of ageing and early development in human populations. Int. J. Epidemiol 2013, 42:1111-1119.
154. Collino S., Montoliu I., Martin F.P., Scherer M., Mari D., Salvioli S., et al. Metabolic signatures of extreme longevity in northern Italian centenarians reveal a complex remodeling of lipids, amino acids, and gut microbiota metabolism. PLoS ONE 2013, 8. e56564.
155. Gonzalez-Covarrubias V., Beekman M., Uh H.-W., Dane A., Troost J., Paliukhovich I., et al. Lipidomics of familial longevity. Aging Cell 2013, 12:426-434.
156. Swann J.R., Spagou K., Lewis M., Nicholson J.K., Glei D.A., Seeman T.E., et al. Microbial-mammalian cometabolites dominate the age-associated urinary metabolic phenotype in Taiwanese and American populations. J. Proteome Res 2013, 12:3166-3180.
157. Bürkle A., Moreno-Villanueva M., Bernhard J., Blasco M., Zondag G., Hoeijmakers J.H.J., et al. MARK-AGE biomarkers of ageing. Mech. Ageing Dev 2015, 151:2-12. http://dx.doi.org/10.1016/j.mad.2015.03.006.
158. Pruitt K.D., Tatusova T., Maglott D.R. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 2007, 35:D61-D65.
159. Kanz C., Aldebert P., Althorpe N., Baker W., Baldwin A., Bates K., et al. The EMBL nucleotide sequence database. Nucleic Acids Res 2005, 33:D29-D33.
160. Flicek P., Amode M.R., Barrell D., Beal K., Brent S., Carvalho-Silva D., et al. Ensembl 2012. Nucleic Acids Res 2011, 40:D84-D90. 10.1093/nar/gkr991.
161. Clarke L., Zheng-Bradley X., Smith R., Kulesha E., Xiao C., Toneva I., et al. The 1000 genomes project: data management and community access. Nat. Methods 2012, 9:459-462.
162. Twigger S.N., Shimoyama M., Bromberg S., Kwitek A.E., Jacob H.J. The rat genome database, update 2007-easing the path from disease to data and back again. Nucleic Acids Res 2007, 35:D658-D662. RGD Team.
163. Bradford Y., Conlin T., Dunn N., Fashena D., Frazer K., Howe D.G., et al. ZFIN: enhancements and updates to the Zebrafish model organism database. Nucleic Acids Res 2011, 39:D822-D829.
164. Tweedie S., Ashburner M., Falls K., Leyland P., McQuilton P., Marygold S., et al. FlyBase: enhancing Drosophila gene ontology annotations. Nucleic Acids Res 2009, 37:D555-D559.
165. Tacutu R., Craig T., Budovsky A., Wuttke D., Lehmann G., Taranukha D., et al. Human ageing genomic resources: integrated databases and tools for the biology and genetics of ageing. Nucleic Acids Res 2012, 41:D1027-D1033. 10.1093/nar/gks1155.
166. Budovsky A., Craig T., Wang J., Tacutu R., Csordas A., Lourenço J., et al. LongevityMap: a database of human genetic variants associated with longevity. Trends Genet 2013, 29:559-560.
167. Hühne R., Thalheim T., Sühnel J. AgeFactDB - the JenAge ageing factor database - towards data integration in ageing research. Nucleic Acids Res 2014, 42:D892-D896.
168. Wishart D.S., Jewison T., Guo A.C., Wilson M., Knox C., Liu Y., et al. HMDB 3.0-The human metabolome database in 2013. Nucleic Acids Res 2013, 41:D801-D807.
169. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30.
170. Cui Q., Lewis I.A., Hegeman A.D., Anderson M.E., Li J., Schulte C.F., et al. Metabolite identification via the madison metabolomics consortium database. Nat. Biotechnol 2008, 26:162-164.
171. Smith C.A., O'Maille G., Want E.J., Qin C., Trauger S.A., Brandon T.R., et al. METLIN: a metabolite mass spectral database. Ther. Drug Monit 2005, 27:747-751.
172. Kopka J., Schauer N., Krueger S., Birkemeyer C., Usadel B., Bergmüller E., et al. GMD@CSB.DB: the golm metabolome database. Bioinformatics 2005, 21:1635-1638.
173. Kosmides A.K., Kamisoglu K., Calvano S.E., Corbett S.A., Androulakis I.P. Metabolomic fingerprinting: challenges and opportunities. Crit. Rev. Biomed. Eng 2013, 41:205-221.
174. Van Assche R., Broeckx V., Boonen K., Maes E., De Haes W., Schoofs L., et al. Integrating-omics: systems biology as explored through C. elegans research. J. Mol. Biol 2015, 427:3441-3451. http://dx.doi.org/10.1016/j.jmb.2015.03.015.
175. van Iersel M.P., Sokolović M., Lenaerts K., Kutmon M., Bouwman F.G., Lamers W.H., et al. Integrated visualization of a multi-omics study of starvation in mouse intestine. J. Integr. Bioinform 2014, 11:235.
176. Dimitrakopoulou K., Vrahatis A., Dimitrakopoulos G., Bezerianos A. Aging integromics: module-based markers of heart aging from multi-omics data. The 15th International Conference on Biomedical Engineering 2014, 104-107. Springer International Publishing. J. Goh (Ed.).
177. Dimitrakopoulou K., Vrahatis A.G., Bezerianos A. Integromics network meta-analysis on cardiac aging offers robust multi-layer modular signatures and reveals micronome synergism. BMC Genomics 2015, 16:147.